H.R. 1628: AMERICAN HEALTH CARE ACT OF 2017; PROVISIONS RELATED TO MEDICAID FUNDING.

SPIKE ACT OF 2017 (DRAFT BILL): PROVISIONS RELATED TO PRESCRIPTION DRUG TRANSPARENCY.

GENERAL DISCUSSION REGARDING PRODUCT LAUNCH.

GENERAL DISCUSSION REGARDING THE ORPHAN DRUG ACT.

GENERAL DISCUSSION REGARDING ACCELERATED APPROVAL FOR SOMATIC CELL GENE THERAPY. GENERAL DISCUSSIONS REGARDING CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAM. GENERAL DISCUSSION REGARDING THE PRESERVATION OF SECTION 45C OF THE INTERNAL REVENUE CODE.

GENERAL DISCUSSION REGARDING TAX CREDITS. H.R. 1628: AMERICAN HEALTH CARE ACT OF 2017; PROVISIONS RELATED TO MEDICAID REFORM. 

S 222: OBAMACARE REPLACEMENT ACT; PROVISIONS RELATED TO MEDICAID REFORM.

GENERAL DISCUSSION REGARDING FOOD AND DRUG ADMINISTRATION IMPLEMENTATION OF MEDICAID REBATE FOR PEDIATRIC DRUGS.
HCR - Health Issues BUD - Budget/Appropriations TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOMARIN PHARMACEUTICAL INC.
770 Lindaro Street, San Rafael, CA, 94901, US
JOHN EDWARD GREISSING (N/A) TERICKE BLANCHARD (N/A) KATHRYN LOWELL (N/A) JOHN EDWARD GREISSING (N/A) JOHN EDWARD GREISSING (N/A) KATHRYN LOWELL (N/A) JOHN EDWARD GREISSING (N/A)
N/A N/A N/A N/A N/A N/A N/A